Kim JW - Search Results

1

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial.

Sugiyama T, Okamoto A, Enomoto T, Hamano T, Aotani E, Terao Y, Suzuki N, Mikami M, Yaegashi N, Kato K, Yoshikawa H, Yokoyama Y, Tanabe H, Nishino K, Nomura H, Kim JW, Kim BG, Pignata S, Alexandre J, Green J, Isonishi S, Terauchi F, Fujiwara K, Aoki D. Sugiyama T, et al. Among authors: kim bg, kim jw. J Clin Oncol. 2016 Aug 20;34(24):2881-7. doi: 10.1200/JCO.2016.66.9010. Epub 2016 Jul 11. J Clin Oncol. 2016. PMID: 27400948 Clinical Trial.

2

Predictive value of individualized tumor response testing by ATP-based chemotherapy response assay in ovarian cancer.

Han SS, Choi SH, Lee YK, Kim JW, Park NH, Song YS, Lee HP, Kang SB. Han SS, et al. Among authors: kim jw. Cancer Invest. 2008 May;26(4):426-30. doi: 10.1080/07357900701813250. Cancer Invest. 2008. PMID: 18443964

3

Are three additional cycles of chemotherapy useful in patients with advanced-stage epithelial ovarian cancer after a complete response to six cycles of intravenous adjuvant paclitaxel and carboplatin?

Kim HS, Park NH, Chung HH, Kim JW, Song YS, Kang SB. Kim HS, et al. Among authors: kim jw. Jpn J Clin Oncol. 2008 Jun;38(6):445-50. doi: 10.1093/jjco/hyn034. Epub 2008 May 27. Jpn J Clin Oncol. 2008. PMID: 18508785 Free PMC article.

4

Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer.

Kim HS, Park NH, Chung HH, Kim JW, Song YS, Kang SB. Kim HS, et al. Among authors: kim jw. Onkologie. 2008 Jun;31(6):315-20. doi: 10.1159/000131270. Epub 2008 May 27. Onkologie. 2008. PMID: 18547972

5

Validation of a nomogram for predicting outcome of vulvar cancer patients, primarily treated by surgery, in Korean population: multicenter retrospective study through Korean Gynecologic Oncology Group (KGOG-1010).

Kim MK, Kim JW, Lee JM, Lee NW, Cha MS, Kim BG, Lee KH, Kim YT, Kim JH, Song ES, Kim MH, Ryu SY, Kim WG, Kim YT, Kim KT, Kang SB. Kim MK, et al. Among authors: kim wg, kim bg, kim kt, kim yt, kim mh, kim jw, kim jh. J Gynecol Oncol. 2008 Sep;19(3):191-4. doi: 10.3802/jgo.2008.19.3.191. Epub 2008 Sep 30. J Gynecol Oncol. 2008. PMID: 19471576 Free PMC article.

6

Phase I/IIa study of combination chemotherapy with CKD-602 and cisplatin in patients with recurrent epithelial ovarian cancer.

Kim HS, Kang SB, Seo SS, Han SS, Kim JW, Park NH, Kang SB, Lee HP, Song YS. Kim HS, et al. Among authors: kim jw. Ann N Y Acad Sci. 2009 Aug;1171:627-34. doi: 10.1111/j.1749-6632.2009.04885.x. Ann N Y Acad Sci. 2009. PMID: 19723113 Clinical Trial.

7

Comparison of the efficacy between topotecan- and belotecan-, a new camptothecin analog, based chemotherapies for recurrent epithelial ovarian cancer: a single institutional experience.

Kim HS, Park NH, Kang S, Seo SS, Chung HH, Kim JW, Song YS, Kang SB. Kim HS, et al. Among authors: kim jw. J Obstet Gynaecol Res. 2010 Feb;36(1):86-93. doi: 10.1111/j.1447-0756.2009.01101.x. J Obstet Gynaecol Res. 2010. PMID: 20178532

8

Comparison of the efficacy between paclitaxel/carboplatin and doxorubicin/cisplatin for concurrent chemoradiation in intermediate- or high-risk endometrioid endometrial cancer: a single institution experience.

Kim HS, Kim JW, Wu HG, Chung HH, Park NH, Song YS, Kang SB, Lee HP. Kim HS, et al. Among authors: kim jw. J Obstet Gynaecol Res. 2010 Jun;36(3):598-604. doi: 10.1111/j.1447-0756.2010.01223.x. J Obstet Gynaecol Res. 2010. PMID: 20598043

9

Matched-case comparison for the efficacy of neoadjuvant chemotherapy before surgery in FIGO stage IB1-IIA cervical cancer.

Kim HS, Kim JY, Park NH, Kim K, Chung HH, Kim YB, Kim JW, Kim HJ, Song YS, Kang SB. Kim HS, et al. Among authors: kim jy, kim hj, kim yb, kim jw, kim k. Gynecol Oncol. 2010 Nov;119(2):217-24. doi: 10.1016/j.ygyno.2010.06.017. Epub 2010 Aug 11. Gynecol Oncol. 2010. PMID: 20705335

10

Epidemiological characteristics of ovarian cancer in Korea.

Park B, Park S, Kim TJ, Ma SH, Kim BG, Kim YM, Kim JW, Kang S, Kim J, Kim TJ, Yoo KY, Park SK. Park B, et al. Among authors: kim ym, kim bg, kim tj, kim j, kim jw. J Gynecol Oncol. 2010 Dec 30;21(4):241-7. doi: 10.3802/jgo.2010.21.4.241. Epub 2010 Dec 31. J Gynecol Oncol. 2010. PMID: 21278886 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,039 results

Search Page

Filters